Cycling: Change in Plans
Lance Armstrong has abandoned his plan to submit to extra performance-enhancing drug tests and make all of the results public to bolster his claims that he competes drug-free, according to the anti-doping chemist Armstrong had pegged to handle the extra testing.
Don Catlin, head of the Los Angeles-based Anti-Doping Research, said yesterday the planned partnership between him and Armstrong would not go forward for a variety of reasons. Armstrong, 37, had trumpeted the proposed arrangement last September when he came out of a three-year retirement to chase his eighth Tour de France title this summer.
Catlin emphasized that Armstrong had not reneged on his promise to allow free rein on testing and the posting of comprehensive results on the Web.
0 comments:
Post a Comment